Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 3176 to 3200 of about 5880

Previous 25

Website Changes

07/09/2009

New Research Grant Awarded by the Grey Ribbon Crusade!

07/09/2009

07/09/2009

Governor Nixon honors brain tumor patients in Missouri by signing House Bill 683

07/09/2009

Governor Nixon honors brain tumor patients in Missouri by signing House Bill 683

07/09/2009

Governor Nixon honors brain tumor patients in Missouri by signing House Bill 683

07/03/2009

Study identifies biomarker that safely monitors tumor response to new brain cancer treatment

07/03/2009

Need help voting for the Grey Ribbon Crusade!

07/02/2009

New Tactics Promising for Prostate, Brain and Pancreatic Cancer

06/30/2009

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

06/30/2009

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.

06/30/2009

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

06/25/2009

FOURTH ANNUAL HAVE A CHANCE WALK TO FIGHT BRAIN TUMORS ANNOUNCED FOR OCTOBER 18th, 2009

06/25/2009

Antigenics Announces Expansion of Investigator-Sponsored Study for Glioma

06/24/2009

ANNUAL NEUROSURGERY CHARITY SOFTBALL TOURNAMENT

06/20/2009

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study.

06/20/2009

Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas

06/20/2009

Bevacizumab (Avastin) and chemotherapy for recurrent glioblastoma: a single-institution experience.

06/20/2009

Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.

06/20/2009

Very late relapses in glioblastoma long-term survivors.

06/20/2009

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.

06/20/2009

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma.

06/20/2009

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab (Avastin)

06/14/2009

Added a translation widget to the bottom of every page!

06/13/2009

Added more videos!

06/12/2009

UPDATE 1-Exelixis brain cancer drug response rates lowered

Our privacy / cookie policy has changed.
Click HERE to read it!